Minerva Neurosciences, Inc. (NERV) Profit Margin
Minerva Neurosciences, Inc. (NERV) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | 4.71% |
| 2021-12-31 | N/A |
| 2022-12-31 | N/A |
| 2023-12-31 | N/A |
| 2024-12-31 | N/A |
| 2025-12-31 | N/A |
How NERV compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| BMY | Bristol-Myers Squibb Company | 14.64% |
| BSX | Boston Scientific Corporation | 14.44% |
| VCYT | Veracyte Inc. | 12.83% |
| PFE | Pfizer Inc. | 12.42% |
| AGEN | Agenus Inc. | -0.09% |
These are five companies in the same sector as NERV with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Minerva Neurosciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("NERV", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | NERV | $4.39 | -4.98% | 0.05M |
| 3 | ||||
| 4 | ||||
| 5 |